The initial coverage and impact of the pneumococcal and influenza vaccination program for at‐risk Indigenous adults in Far North Queensland

Hanna, 1997, Pneumococcal vaccination: an important strategy to prevent pneumonia in Aboriginal and Torres Strait Island adults, Aust N Z J Public Health, 21, 281, 10.1111/j.1467-842X.1997.tb01700.x 1998 Young, 1998, Successful strategies for an adult immunisation program, Health Promot J Aust, 8, 59 1997, 138 Selvey, 1998, A state‐based vaccination register [letter], Med J Aust, 169, 59, 10.5694/j.1326-5377.1998.tb141491.x Bailar, 1964, Significance factors for the ratio of a Poisson variable to its expectation, Biometrics, 20, 639, 10.2307/2528501 Jacobson, 1999, Use of a low‐literacy patient education tool to enhance pneumococcal vaccination rates: a randomised clinical trial, J Am Med Assoc, 282, 646, 10.1001/jama.282.7.646 1998, Influenza and pneumococcal vaccination levels among adults aged ≥65 years — United States, 1997, MMWR Morb Mortal Wkly Rep, 47, 797 2000, 183 Nuorti, 2000, Cigarette smoking and invasive pneumococcal disease, N Engl J Med, 342, 681, 10.1056/NEJM200003093421002 1999 Krause, 2000, Invasive pneumococcal disease in the Northern Territory of Australia, 1994–1998, Med J Aust, 173, S27, 10.5694/j.1326-5377.2000.tb139410.x 2001, Cigarette smoking: A powerful determinant of invasive pneumococcal disease, TPHU Comm Dis Control Newsletter, 3 1995, Prevention of pneumonia in Aboriginal adults through immunisation, TPHU Comm Dis Control Newsl, 2 Fedson, 1999, The clinical effectiveness of pneumococcal vaccination: a brief review, Vaccine, 17, S85, 10.1016/S0264-410X(99)00113-9 Hanna, 2000, Three fatal pneumococcal polysaccharide vaccine failures, Med J Aust, 173, 305, 10.5694/j.1326-5377.2000.tb125662.x Green K., Landry L., Goldenberg E., et al. Effectiveness of a pneumococcal vaccination program in preventing invasive pneumococcal disease. The 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1999 26–29; San Fransisco CA. Christenson, 2001, Effects of a large‐scale intervention with influenza and 23‐valent pneumococcal vaccines in adults aged 65 years or older: a prospective study, Lancet, 357, 1008, 10.1016/S0140-6736(00)04237-9 Nichol, 1999, The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease, Arch Intern Med, 159, 2437, 10.1001/archinte.159.20.2437 Nichol, 1999, The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic ling disease, Vaccine, 17, S91, 10.1016/S0264-410X(99)00114-0 Sankilampi, 1997, Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly, J Infect Dis, 176, 1100, 10.1086/516521 Jackson, 1999, Safety of revaccination with pneumococcal polysaccharide vaccine, J Am Med Assoc, 281, 243, 10.1001/jama.281.3.243